These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8834657)

  • 1. [Influence of long-term human recombinant erythropoietin treatment on secretion of pancreatic polypeptide and gastrin in hemodialysed patients with chronic renal failure].
    Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
    Przegl Lek; 1995; 52(12):590-3. PubMed ID: 8834657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of long-term erythropoietin treatment on insulin, glucagon, pancreatic polypeptide, and gastrin secretion in haemodialysed patients.
    Kokot F; Nieszporek T; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
    Nephrol Dial Transplant; 1994; 9 Suppl 3():35-9. PubMed ID: 8072722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of long-term treatment with human recombinant erythropoietin on secretion of hormones regulating carbohydrate metabolism in hemodialyzed patients with chronic uremia].
    Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
    Pol Arch Med Wewn; 1995 Dec; 94(6):488-94. PubMed ID: 8618811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of hemodialysis on levels of beta-endorphin in serum of patients with chronic renal failure treated with erythropoietin].
    Burak W; Grzeszczak W; Trelewicz P; Zukowska-Szczechowska E
    Przegl Lek; 1996; 53(2):54-7. PubMed ID: 8754321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of long-term erythropoietin therapy on endocrine abnormalities in haemodialyzed patients.
    Kokot F; Wiecek A; Schmidt-Gayk H; Marcinkowski W; Nieszporek T; Rudka R; Trembecki J
    Przegl Lek; 1992; 49(1-2):43-9. PubMed ID: 1455006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
    Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
    Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.
    Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P
    Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of recombinant erythropoietin on candidicidal activity of polymorphonuclear leukocytes in hemodialyzed patients].
    Bartůnková J; Sulková S; Cebecauer M
    Cas Lek Cesk; 1995 Dec; 134(23):756-9. PubMed ID: 8599817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
    Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
    Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of erythropoietin therapy on alpha receptor density in chronic dialysis patients].
    Fritschka E; Neumayer HH; Seddighi S; Distler A; Philipp T
    Med Klin (Munich); 1991 Jul; 86(7):353-9. PubMed ID: 1656181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improvement of sexual function in hemodialyzed male patients with chronic renal failure treated with erythropoietin (rHuEPO)].
    Trembecki J; Kokot F; Wiecek A; Marcinkowski W; Rudka R
    Przegl Lek; 1995; 52(9):462-6. PubMed ID: 8834648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.
    Stasko J; Galajda P; Ivanková J; Hollý P; Rozborilová E; Kubisz P
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):410-5. PubMed ID: 17911193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of erythropoietin treatment on function of the pituitary-adrenal axis and somatotropin secretion in hemodialyzed patients.
    Kokot F; Wiecek A; Grzeszczak W; Klin M
    Clin Nephrol; 1990 May; 33(5):241-6. PubMed ID: 2162262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices.
    Trkulja V
    Med Hypotheses; 2012 Jan; 78(1):157-61. PubMed ID: 22078846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte PC-1 activity in patients on maintenance haemodialysis treated with human erythropoietin and 1-alpha-D3.
    Stefanovic V; Djordjevic V; Ivic M; Mitic-Zlatkovic M; Vlahovic P
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):55-60. PubMed ID: 15802034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anemia management in haemodialysis. EuCliD database in Spain].
    Avilés B; Coronel F; Pérez-García R; Marcelli D; Orlandini G; Ayala JA; Rentero R
    Nefrologia; 2002; 22(6):555-63. PubMed ID: 12516289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemical structure, biotechnical production and clinical use of recombinant erythropoietin].
    Fandrey JK; Jelkmann WE
    Z Gesamte Inn Med; 1992 Jun; 47(6):231-8. PubMed ID: 1642021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid deficiency modifies the haematopoietic response to recombinant human erythropoietin in maintenance dialysis patients.
    Schiffl H; Lang SM
    Nephrol Dial Transplant; 2006 Jan; 21(1):133-7. PubMed ID: 16144854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of recombinant human erythropoietin--rHu-EPO on the metabolism of children treated by long-term hemodialysis].
    Pietrzyk JA; Smolnik T; Szymowska M; Dyras P; Lenik J
    Przegl Lek; 1992; 49(1-2):55-60. PubMed ID: 1455008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of red blood cell indices (MCV, MCH, RDW) in monitoring chronic hemodialysis patients treated with recombinant erythropoietin.
    Fialon P; Leaute AG; Sassier P; Vallot C; Wone C
    Pathol Biol (Paris); 1993 Dec; 41(10):931-5. PubMed ID: 8159473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.